CRH (CRH) Earnings Analysis
CRH (CRH) next reports earnings on 2026-07-30, consensus EPS 2.02 USD. Last quarter (2026-04-30) it missed with EPS -0.27 USD vs -0.21868 USD est (-23.5%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E 17.10.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CRH next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 2.02 USD |
| Revenue estimate | 10.67B |
CRH earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | -0.27 USD | -0.21868 USD | -23.5% | Miss |
| 2026-02-18 | 1.52 USD | 1.52 USD | 0% | Beat |
| 2025-05-05 | -0.13789 USD | -0.078 USD | -76.8% | Miss |
| 2025-02-26 | 1.45 USD | 1.44 USD | +0.7% | Beat |
| 2024-11-07 | 1.77 USD | 2.1 USD | -15.7% | Miss |
| 2024-08-08 | 1.95 USD | 2.1 USD | -7.1% | Miss |
Beat rate: 2/6 (33%) over reported quarters with consensus data.
CRH valuation and analyst view
| Trailing P/E | 17.10 |
|---|---|
| Trailing EPS | 7.559 USD |
| Price / book | 2.90 |
| Dividend yield | 1.52% |
| Market cap | 66.85B |
| Analyst consensus | Buy (14 buy / 6 hold / 0 sell) |
| Avg price target | 148.8 USD |
Related research pages
Frequently asked questions
When is CRH (CRH)'s next earnings date?
CRH is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 2.02 USD and revenue estimate of 10.67B.
Did CRH beat earnings last quarter?
In its 2026-04-30 report, CRH posted EPS of -0.27 USD versus a -0.21868 USD estimate — a miss of 23.5%.
What is CRH's earnings track record?
Over the last 6 reported quarters with consensus data, CRH beat estimates 2 times (33%).
What is CRH's current P/E ratio and EPS?
CRH trades at a trailing P/E of 17.10 on trailing EPS of 7.558713537771129 USD.
What do analysts rate CRH?
Analyst consensus is "Buy" across 20 ratings (0 strong buy, 14 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 148.8 USD.